# Probiotics in GastroIntestinal Disorders

> **NCT00510978** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University College Cork** · enrollment: 360 (actual)

## Conditions studied

- Ulcerative Colitis
- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Bifidobacterium infantis 35624
- **BIOLOGICAL:** Lactobacillus salivarius UCC118
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00510978
- **Lead sponsor:** University College Cork
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2011-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510978, "Probiotics in GastroIntestinal Disorders". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00510978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*